Skip to content
Norton & Elaine Sarnoff Center for Jewish Genetics Logo
  • Home
  • About Us
    • Board Members
    • Staff
  • Genetic Disorders
    • Types of Genetic Disorders
    • Jewish Genetic Disorder FAQs
    • Rabbinical Insights
  • Hereditary Cancer
    • BRCA Mutations
    • Lynch Syndrome
    • Assess Your Risk
    • Cancer FAQs
    • Cancer Resources
  • Resources
    • Family Health History
    • Teach Jewish Genetics
    • For Medical Professionals
    • Personal Stories
    • Blog
    • Events
  • Donate
  • Get Screened

Mitochondrial Neurogastrointestinal Encephalopathy Disease

Mitochondrial neurogastrointestinal encephalopathy disease, or MNGIE, is a condition that impacts various parts of the body, such as the digestive system, nerves, brain, and eyes.

Symptoms usually start around 18 years old, but they can appear anywhere from 5 months to 40 years. Digestive problems and eye issues are often the first signs, including diarrhea, abdominal pain, nausea, difficulty swallowing, and muscle weakness in the eyes. Nerve damage may cause numbness, weakness, cramps, or hearing loss. Some individuals also develop brain abnormalities, leading to cognitive issues, seizures, or headaches. While there’s no cure for MNGIE, symptoms can be managed. Swallowing difficulties can be addressed, and medications may help with nausea and nerve-related symptoms. Nutritional support through a feeding tube and therapy to maintain mobility can also be beneficial.

MNGIE is caused by pathogenic (disease-causing) variants in the TYMP gene and exhibits autosomal recessive inheritance. This means that both parents must be carriers to have a 25% chance to have a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background. For example, individuals of Sephardic Jewish descent have a 1 in 158 chance to be a carrier. 

Other names for this condition are mitochondrial myopathy with sensorimotor polyneuropathy, ophthalmoplegia, and pseudo-obstruction, MNGIE syndrome, myoneurogastrointestinal encephalopathy syndrome, oculogastrointestinal muscular dystrophy, polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudo-obstruction, and thymidine phosphorylase deficiency.

Resources:  

Medline Plus

MNGIE Connect

Revised November 2023

Share this
Tweet this
Email this

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of the Jewish United Fund, and is supported in part by the Michael Reese Health Trust.

30 S Wells
Chicago, IL 60606
312-357-4718
jewishgenetics@juf.org

Twitter/X
About
  • About Us
  • Genetic Disorders
  • Hereditary Cancer
  • Donate
Resources
  • Medical Professionals
  • Teach Jewish Genetics
  • Events

©2023 Norton & Elaine Sarnoff Center for Jewish Genetics

Page load link
Go to Top